4 things to know about Datum Orthobiologics, a newly formed company

Written by Shayna Korol | April 25, 2018 | Print  |

Datum Orthobiologics was recently founded to provide orthopedic ossification, bone formation and tissue regeneration solutions.

Here are four things to know.

1. Datum Orthobiologics is affiliated with Datum Biotech, whose proprietary Glymatrix technology has been used in over 500,000 clinical dental and aesthetic procedures. There are more than 110 scientific publications and several case studies about the technology.

2. The new company will initially focus on bone graft products, particularly for spine fusion and fracture grafts in trauma.

3. Gilad Karni was appointed CEO of the newly formed company.

4. Datum Orthobiologics is currently in a fundraising round.

More articles on biologics:

Siberian tiger receives stem cell treatment for joint pain — 3 insights

Texas Back Institute heads stem cell trial for rejuvenating spinal tissue— 5 notes

2-D nanoparticles can direct mesenchymal stem cells to become bone, cartilage — 5 takeaways

© Copyright ASC COMMUNICATIONS 2019. Interested in LINKING to or REPRINTING this content? View our policies here.

Top 40 Articles from the Past 6 Months